DORSAVI LTD - Announcements

6.49%

4.1¢

Market Cap $37.35M

Industrials Business Equipment

dorsaVi Ltd is an Australia-based company focused on developing motion analysis device... dorsaVi Ltd is an Australia-based company focused on developing motion analysis device technologies for use in clinical applications, elite sports, and occupational health and safety. Its segments include Clinical and Workplace. The Company's products include Workplace Solutions, ViMove+, ViSafe, and Research+. Workplace Solution enables employers to assess risk of injury for employees as well as test the effectiveness of proposed changes to OHS workplace design, equipment or methods based on objective evidence. Its clinical solutions (ViMove, ViMove2 and Professional Suite) provides objective assessment, monitoring outside the clinic and immediate biofeedback. The clinical market is segmented into physical therapy (physiotherapists), hospital in the home, and elite sports. Hospital in the home refers to the remote management of patients by clinicians outside of physical therapy. Elite sports refer to the management and optimization of athletes through objective evidence.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

DVL	dorsaVi signs second stage evaluation agreement with Stryker	PRICE SENSITIVE	24/02/20	171.96KB	Share
DVL	Appendix 4C	PRICE SENSITIVE	31/01/20	498.07KB	Share
DVL	Heathrow Airport signs repeat contract with dorsaVi	PRICE SENSITIVE	29/01/20	172.35KB	Share
DVL	Share Purchase Plan Announcement	PRICE SENSITIVE	30/12/19	120.29KB	Share
DVL	Share Purchase Plan Offer Document Despatch	PRICE SENSITIVE	03/12/19	668.03KB	Share
DVL	2019 Annual General Meeting Opening Address	PRICE SENSITIVE	28/11/19	280.76KB	Share
DVL	Share Purchase Plan Offer	PRICE SENSITIVE	28/11/19	140.56KB	Share
DVL	$1.7m Capital Raising & Share Purchase Plan of up to $1.0m	PRICE SENSITIVE	28/11/19	141.61KB	Share
DVL	Trading Halt	PRICE SENSITIVE	26/11/19	319.22KB	Share
DVL	Investor Update	PRICE SENSITIVE	19/11/19	1.35MB	Share
DVL	dorsaVi adds to growing patent portfolio	PRICE SENSITIVE	18/11/19	212.27KB	Share
DVL	Reinstatement to Official Quotation	PRICE SENSITIVE	14/11/19	216.67KB	Share
DVL	BUSINESS OPERATIONS UPDATE	PRICE SENSITIVE	14/11/19	201.2KB	Share
DVL	Suspension from Official Quotation	PRICE SENSITIVE	11/11/19	430KB	Share
DVL	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/19	1015.99KB	Share
DVL	Business Update and Results Announcement	PRICE SENSITIVE	29/08/19	245.93KB	Share
DVL	Appendix 4E and Annual Report	PRICE SENSITIVE	29/08/19	1.62MB	Share
DVL	CEO Investor Update	PRICE SENSITIVE	29/07/19	1.42MB	Share
DVL	Appendix 4C - quarterly	PRICE SENSITIVE	29/07/19	1MB	Share
DVL	Appendix 4C	PRICE SENSITIVE	30/04/19	880.96KB	Share
DVL	dorsaVi makes large myViSafe UK sale	PRICE SENSITIVE	08/04/19	1.11MB	Share
DVL	Response to ASX Query Letter	PRICE SENSITIVE	27/03/19	13.17MB	Share
DVL	dorsaVi Ltd announces operational changes	PRICE SENSITIVE	15/03/19	290.23KB	Share
DVL	Half Year Results Announcement	PRICE SENSITIVE	28/02/19	235.16KB	Share
DVL	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	28/02/19	1.07MB	Share
DVL	Appendix 4C	PRICE SENSITIVE	31/01/19	881.3KB	Share
DVL	Allotment of Shares under Rights Issue	PRICE SENSITIVE	21/12/18	322.03KB	Share
DVL	Significant support from shareholders for Rights Issue	PRICE SENSITIVE	18/12/18	324.48KB	Share
DVL	Trading halt	PRICE SENSITIVE	17/12/18	275.37KB	Share
DVL	dorsaVi signs large US project with Work Right NW	PRICE SENSITIVE	22/11/18	1.12MB	Share
DVL	2018 Annual General Meeting Opening Address	PRICE SENSITIVE	21/11/18	500.42KB	Share
DVL	Offer Statement	PRICE SENSITIVE	21/11/18	266.49KB	Share
DVL	dorsaVi announces non-renounceable rights offer	PRICE SENSITIVE	21/11/18	337.82KB	Share
DVL	US Patent Granted	PRICE SENSITIVE	15/11/18	206.51KB	Share
DVL	CEO Investor Presentation	PRICE SENSITIVE	14/11/18	9.06MB	Share
DVL	Appendix 4C	PRICE SENSITIVE	29/10/18	523.76KB	Share
DVL	Appendix 4E	PRICE SENSITIVE	31/08/18	326.44KB	Share
DVL	Appendix 4C - quarterly	PRICE SENSITIVE	23/07/18	891.19KB	Share
DVL	Stryker to assess ViMove2	PRICE SENSITIVE	18/07/18	159.77KB	Share
DVL	dorsaVi signs deal with CitiPower and Powercor	PRICE SENSITIVE	03/07/18	87.86KB	Share
DVL	dorsaVi launches Professional Suite in USA	PRICE SENSITIVE	25/06/18	91.97KB	Share
DVL	US Knee Patent Granted	PRICE SENSITIVE	19/06/18	205.39KB	Share
DVL	dorsaVi USA signs deal with AIG	PRICE SENSITIVE	22/05/18	87.7KB	Share
DVL	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/18	945.5KB	Share
DVL	Low back trial to adopt dorsaVi technology	PRICE SENSITIVE	10/04/18	174.68KB	Share
DVL	Stryker signs ViSafe contract with dorsaVi	PRICE SENSITIVE	22/02/18	164.43KB	Share
DVL	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	15/02/18	3.49MB	Share
DVL	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/18	1.03MB	Share
DVL	Appendix 4C	PRICE SENSITIVE	31/10/17	984.85KB	Share
DVL	Japara Healthcare adopts dorsaVi myViSafe	PRICE SENSITIVE	25/10/17	66.94KB	Share
DVL	dorsaVi awarded Advanced Manufacturing Growth Fund grant	PRICE SENSITIVE	18/10/17	56.43KB	Share
DVL	Appendix 4E Preliminary Financial Report and Annual Report	PRICE SENSITIVE	28/08/17	3.7MB	Share
DVL	dorsaVi Investor Update	PRICE SENSITIVE	31/07/17	5.96MB	Share
DVL	Appendix 4C	PRICE SENSITIVE	31/07/17	576.85KB	Share
DVL	ViMove receives FDA Clearance	PRICE SENSITIVE	19/07/17	141.07KB	Share
DVL	ViMove validate Pfizer supported study	PRICE SENSITIVE	29/06/17	124.36KB	Share
DVL	Kieser Australia signs three-year deal to use ViMove2	PRICE SENSITIVE	14/06/17	301.01KB	Share
DVL	dorsaVi announces the launch of ViMove2	PRICE SENSITIVE	15/05/17	160.99KB	Share
DVL	Snowy Hydro signs with dorsaVi	PRICE SENSITIVE	11/05/17	1.09MB	Share
DVL	dorsaVi China Patent	PRICE SENSITIVE	04/05/17	126.18KB	Share
DVL	Appendix 4C	PRICE SENSITIVE	27/04/17	264.92KB	Share
DVL	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	16/02/17	569.19KB	Share
DVL	Appendix 4C	PRICE SENSITIVE	30/01/17	2.15MB	Share
DVL	dorsaVi Health Economics Paper	PRICE SENSITIVE	18/01/17	434.25KB	Share
DVL	Heathrow Airport undertaking 12-month project with dorsaVi	PRICE SENSITIVE	19/12/16	90.93KB	Share
DVL	Share Purchase Plan Offer	PRICE SENSITIVE	13/12/16	147.21KB	Share
DVL	$7M Private Placement and $1M Share Purchase Plan	PRICE SENSITIVE	13/12/16	100.59KB	Share
DVL	Trading Halt	PRICE SENSITIVE	09/12/16	326.01KB	Share
DVL	dorsaVi signs new US sales agent for ViSafe	PRICE SENSITIVE	06/12/16	558.81KB	Share
DVL	dorsaVi announces the launch of myViSafe	PRICE SENSITIVE	01/12/16	71.38KB	Share
DVL	dorsaVi and Mizuno working together	PRICE SENSITIVE	28/11/16	66.48KB	Share
DVL	dorsaVi launches US based patient registry-DVL.AX	PRICE SENSITIVE	27/10/16	68.83KB	Share
DVL	Appendix 4C - quarterly-DVL.AX	PRICE SENSITIVE	17/10/16	1.53MB	Share
DVL	dorsaVi awarded a Future Industries Manufacturing Grant-DVL.AX	PRICE SENSITIVE	29/09/16	87.32KB	Share
DVL	Appendix 4E Preliminary Final Report and Annual Accounts-DVL.AX	PRICE SENSITIVE	28/08/16	1.42MB	Share
DVL	Appendix 4E Preliminary Final Report and Annual Accounts-DVL.AX	PRICE SENSITIVE	25/08/16	1.42MB	Share
DVL	dorsaVi announces release of ViPerform AMI in USA-DVL.AX	PRICE SENSITIVE	18/08/16	347.85KB	Share
DVL	dorsaVi ViMove being used by Wake Forest-DVL.AX	PRICE SENSITIVE	09/08/16	342.64KB	Share
DVL	Appendix 4C - quarterly-DVL.AX	PRICE SENSITIVE	28/07/16	423.63KB	Share
DVL	dorsaVi USA market update-DVL.AX	PRICE SENSITIVE	06/07/16	359.37KB	Share
DVL	Appendix 4C - quarterly-DVL.AX	PRICE SENSITIVE	27/04/16	766.5KB	Share
DVL	Major US physical therapy provider adopts dorsaVi products	PRICE SENSITIVE	24/02/16	100.69KB	Share
DVL	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	08/02/16	627.13KB	Share
DVL	dorsaVi signs Jaguar Land Rover and Toyota	PRICE SENSITIVE	03/02/16	90.33KB	Share
DVL	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/16	242.89KB	Share
DVL	London Underground expand use of ViSafe wearable tech	PRICE SENSITIVE	28/01/16	419.79KB	Share
DVL	Allianz, Monash Health and dorsaVi team up	PRICE SENSITIVE	19/11/15	104.01KB	Share
DVL	Appendix 4C - quarterly	PRICE SENSITIVE	22/10/15	219.02KB	Share
DVL	Three year agreement signed with UK physiotherapy network	PRICE SENSITIVE	29/09/15	92.44KB	Share
DVL	Appendix 4E - Preliminary Final Report	PRICE SENSITIVE	26/08/15	260.25KB	Share
DVL	Non-renounceable Rights Offer Statement	PRICE SENSITIVE	26/08/15	233.89KB	Share
DVL	Institutional Placement and Non-renounceable Rights Offer	PRICE SENSITIVE	26/08/15	129.21KB	Share
DVL	Trading Halt	PRICE SENSITIVE	24/08/15	266.76KB	Share
DVL	dorsaVi signs Sodexo to improve workplace safety	PRICE SENSITIVE	20/08/15	105.64KB	Share
DVL	dorsaVi signs Crown Resorts, its largest contract to date.	PRICE SENSITIVE	17/08/15	91.06KB	Share
DVL	Appendix 4C - quarterly	PRICE SENSITIVE	16/07/15	251.21KB	Share
DVL	dorsaVi CPT coding and US reimbursement strategy	PRICE SENSITIVE	19/06/15	92.5KB	Share
DVL	dorsaVi signs UK physiotherapy network	PRICE SENSITIVE	02/06/15	189.49KB	Share
DVL	Clinical Trial using dorsaVi shows reduction in back pain	PRICE SENSITIVE	01/06/15	428.97KB	Share
DVL	FDA approves ViMove for expanded US use	PRICE SENSITIVE	01/06/15	172.58KB	Share

DVL dorsaVi signs second stage evaluation agreement with Stryker
24/02/20	PRICE SENSITIVE	171.96KB	Share
DVL Appendix 4C
31/01/20	PRICE SENSITIVE	498.07KB	Share
DVL Heathrow Airport signs repeat contract with dorsaVi
29/01/20	PRICE SENSITIVE	172.35KB	Share
DVL Share Purchase Plan Announcement
30/12/19	PRICE SENSITIVE	120.29KB	Share
DVL Share Purchase Plan Offer Document Despatch
03/12/19	PRICE SENSITIVE	668.03KB	Share
DVL 2019 Annual General Meeting Opening Address
28/11/19	PRICE SENSITIVE	280.76KB	Share
DVL Share Purchase Plan Offer
28/11/19	PRICE SENSITIVE	140.56KB	Share
DVL $1.7m Capital Raising & Share Purchase Plan of up to $1.0m
28/11/19	PRICE SENSITIVE	141.61KB	Share
DVL Trading Halt
26/11/19	PRICE SENSITIVE	319.22KB	Share
DVL Investor Update
19/11/19	PRICE SENSITIVE	1.35MB	Share
DVL dorsaVi adds to growing patent portfolio
18/11/19	PRICE SENSITIVE	212.27KB	Share
DVL Reinstatement to Official Quotation
14/11/19	PRICE SENSITIVE	216.67KB	Share
DVL BUSINESS OPERATIONS UPDATE
14/11/19	PRICE SENSITIVE	201.2KB	Share
DVL Suspension from Official Quotation
11/11/19	PRICE SENSITIVE	430KB	Share
DVL Appendix 4C - quarterly
31/10/19	PRICE SENSITIVE	1015.99KB	Share
DVL Business Update and Results Announcement
29/08/19	PRICE SENSITIVE	245.93KB	Share
DVL Appendix 4E and Annual Report
29/08/19	PRICE SENSITIVE	1.62MB	Share
DVL CEO Investor Update
29/07/19	PRICE SENSITIVE	1.42MB	Share
DVL Appendix 4C - quarterly
29/07/19	PRICE SENSITIVE	1MB	Share
DVL Appendix 4C
30/04/19	PRICE SENSITIVE	880.96KB	Share
DVL dorsaVi makes large myViSafe UK sale
08/04/19	PRICE SENSITIVE	1.11MB	Share
DVL Response to ASX Query Letter
27/03/19	PRICE SENSITIVE	13.17MB	Share
DVL dorsaVi Ltd announces operational changes
15/03/19	PRICE SENSITIVE	290.23KB	Share
DVL Half Year Results Announcement
28/02/19	PRICE SENSITIVE	235.16KB	Share
DVL Appendix 4D and Half Year Financial Report
28/02/19	PRICE SENSITIVE	1.07MB	Share
DVL Appendix 4C
31/01/19	PRICE SENSITIVE	881.3KB	Share
DVL Allotment of Shares under Rights Issue
21/12/18	PRICE SENSITIVE	322.03KB	Share
DVL Significant support from shareholders for Rights Issue
18/12/18	PRICE SENSITIVE	324.48KB	Share
DVL Trading halt
17/12/18	PRICE SENSITIVE	275.37KB	Share
DVL dorsaVi signs large US project with Work Right NW
22/11/18	PRICE SENSITIVE	1.12MB	Share
DVL 2018 Annual General Meeting Opening Address
21/11/18	PRICE SENSITIVE	500.42KB	Share
DVL Offer Statement
21/11/18	PRICE SENSITIVE	266.49KB	Share
DVL dorsaVi announces non-renounceable rights offer
21/11/18	PRICE SENSITIVE	337.82KB	Share
DVL US Patent Granted
15/11/18	PRICE SENSITIVE	206.51KB	Share
DVL CEO Investor Presentation
14/11/18	PRICE SENSITIVE	9.06MB	Share
DVL Appendix 4C
29/10/18	PRICE SENSITIVE	523.76KB	Share
DVL Appendix 4E
31/08/18	PRICE SENSITIVE	326.44KB	Share
DVL Appendix 4C - quarterly
23/07/18	PRICE SENSITIVE	891.19KB	Share
DVL Stryker to assess ViMove2
18/07/18	PRICE SENSITIVE	159.77KB	Share
DVL dorsaVi signs deal with CitiPower and Powercor
03/07/18	PRICE SENSITIVE	87.86KB	Share
DVL dorsaVi launches Professional Suite in USA
25/06/18	PRICE SENSITIVE	91.97KB	Share
DVL US Knee Patent Granted
19/06/18	PRICE SENSITIVE	205.39KB	Share
DVL dorsaVi USA signs deal with AIG
22/05/18	PRICE SENSITIVE	87.7KB	Share
DVL Appendix 4C - quarterly
30/04/18	PRICE SENSITIVE	945.5KB	Share
DVL Low back trial to adopt dorsaVi technology
10/04/18	PRICE SENSITIVE	174.68KB	Share
DVL Stryker signs ViSafe contract with dorsaVi
22/02/18	PRICE SENSITIVE	164.43KB	Share
DVL Appendix 4D and Half Year Financial Report
15/02/18	PRICE SENSITIVE	3.49MB	Share
DVL Appendix 4C - quarterly
31/01/18	PRICE SENSITIVE	1.03MB	Share
DVL Appendix 4C
31/10/17	PRICE SENSITIVE	984.85KB	Share
DVL Japara Healthcare adopts dorsaVi myViSafe
25/10/17	PRICE SENSITIVE	66.94KB	Share
DVL dorsaVi awarded Advanced Manufacturing Growth Fund grant
18/10/17	PRICE SENSITIVE	56.43KB	Share
DVL Appendix 4E Preliminary Financial Report and Annual Report
28/08/17	PRICE SENSITIVE	3.7MB	Share
DVL dorsaVi Investor Update
31/07/17	PRICE SENSITIVE	5.96MB	Share
DVL Appendix 4C
31/07/17	PRICE SENSITIVE	576.85KB	Share
DVL ViMove receives FDA Clearance
19/07/17	PRICE SENSITIVE	141.07KB	Share
DVL ViMove validate Pfizer supported study
29/06/17	PRICE SENSITIVE	124.36KB	Share
DVL Kieser Australia signs three-year deal to use ViMove2
14/06/17	PRICE SENSITIVE	301.01KB	Share
DVL dorsaVi announces the launch of ViMove2
15/05/17	PRICE SENSITIVE	160.99KB	Share
DVL Snowy Hydro signs with dorsaVi
11/05/17	PRICE SENSITIVE	1.09MB	Share
DVL dorsaVi China Patent
04/05/17	PRICE SENSITIVE	126.18KB	Share
DVL Appendix 4C
27/04/17	PRICE SENSITIVE	264.92KB	Share
DVL Appendix 4D and Half Year Financial Report
16/02/17	PRICE SENSITIVE	569.19KB	Share
DVL Appendix 4C
30/01/17	PRICE SENSITIVE	2.15MB	Share
DVL dorsaVi Health Economics Paper
18/01/17	PRICE SENSITIVE	434.25KB	Share
DVL Heathrow Airport undertaking 12-month project with dorsaVi
19/12/16	PRICE SENSITIVE	90.93KB	Share
DVL Share Purchase Plan Offer
13/12/16	PRICE SENSITIVE	147.21KB	Share
DVL $7M Private Placement and $1M Share Purchase Plan
13/12/16	PRICE SENSITIVE	100.59KB	Share
DVL Trading Halt
09/12/16	PRICE SENSITIVE	326.01KB	Share
DVL dorsaVi signs new US sales agent for ViSafe
06/12/16	PRICE SENSITIVE	558.81KB	Share
DVL dorsaVi announces the launch of myViSafe
01/12/16	PRICE SENSITIVE	71.38KB	Share
DVL dorsaVi and Mizuno working together
28/11/16	PRICE SENSITIVE	66.48KB	Share
DVL dorsaVi launches US based patient registry-DVL.AX
27/10/16	PRICE SENSITIVE	68.83KB	Share
DVL Appendix 4C - quarterly-DVL.AX
17/10/16	PRICE SENSITIVE	1.53MB	Share
DVL dorsaVi awarded a Future Industries Manufacturing Grant-DVL.AX
29/09/16	PRICE SENSITIVE	87.32KB	Share
DVL Appendix 4E Preliminary Final Report and Annual Accounts-DVL.AX
28/08/16	PRICE SENSITIVE	1.42MB	Share
DVL Appendix 4E Preliminary Final Report and Annual Accounts-DVL.AX
25/08/16	PRICE SENSITIVE	1.42MB	Share
DVL dorsaVi announces release of ViPerform AMI in USA-DVL.AX
18/08/16	PRICE SENSITIVE	347.85KB	Share
DVL dorsaVi ViMove being used by Wake Forest-DVL.AX
09/08/16	PRICE SENSITIVE	342.64KB	Share
DVL Appendix 4C - quarterly-DVL.AX
28/07/16	PRICE SENSITIVE	423.63KB	Share
DVL dorsaVi USA market update-DVL.AX
06/07/16	PRICE SENSITIVE	359.37KB	Share
DVL Appendix 4C - quarterly-DVL.AX
27/04/16	PRICE SENSITIVE	766.5KB	Share
DVL Major US physical therapy provider adopts dorsaVi products
24/02/16	PRICE SENSITIVE	100.69KB	Share
DVL Appendix 4D and Half Year Financial Report
08/02/16	PRICE SENSITIVE	627.13KB	Share
DVL dorsaVi signs Jaguar Land Rover and Toyota
03/02/16	PRICE SENSITIVE	90.33KB	Share
DVL Appendix 4C - quarterly
29/01/16	PRICE SENSITIVE	242.89KB	Share
DVL London Underground expand use of ViSafe wearable tech
28/01/16	PRICE SENSITIVE	419.79KB	Share
DVL Allianz, Monash Health and dorsaVi team up
19/11/15	PRICE SENSITIVE	104.01KB	Share
DVL Appendix 4C - quarterly
22/10/15	PRICE SENSITIVE	219.02KB	Share
DVL Three year agreement signed with UK physiotherapy network
29/09/15	PRICE SENSITIVE	92.44KB	Share
DVL Appendix 4E - Preliminary Final Report
26/08/15	PRICE SENSITIVE	260.25KB	Share
DVL Non-renounceable Rights Offer Statement
26/08/15	PRICE SENSITIVE	233.89KB	Share
DVL Institutional Placement and Non-renounceable Rights Offer
26/08/15	PRICE SENSITIVE	129.21KB	Share
DVL Trading Halt
24/08/15	PRICE SENSITIVE	266.76KB	Share
DVL dorsaVi signs Sodexo to improve workplace safety
20/08/15	PRICE SENSITIVE	105.64KB	Share
DVL dorsaVi signs Crown Resorts, its largest contract to date.
17/08/15	PRICE SENSITIVE	91.06KB	Share
DVL Appendix 4C - quarterly
16/07/15	PRICE SENSITIVE	251.21KB	Share
DVL dorsaVi CPT coding and US reimbursement strategy
19/06/15	PRICE SENSITIVE	92.5KB	Share
DVL dorsaVi signs UK physiotherapy network
02/06/15	PRICE SENSITIVE	189.49KB	Share
DVL Clinical Trial using dorsaVi shows reduction in back pain
01/06/15	PRICE SENSITIVE	428.97KB	Share
DVL FDA approves ViMove for expanded US use
01/06/15	PRICE SENSITIVE	172.58KB	Share

REFRESH

First 2

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 4.1¢		Change 0.003(6.49%)		Mkt cap ! $37.35M

Open	High	Low	Value	Volume
3.9¢	4.1¢	3.9¢	$128.6K	3.227M

Buyers (Bids)

No.	Vol.	Price($)
7	1404032	4.0¢

Sellers (Offers)

Price($)	Vol.	No.
4.1¢	977681	6

View Market Depth

No.	Vol.	Price($)
7	1404032	0.040
7	1493528	0.039
4	1878342	0.038
2	3255000	0.037
2	1208572	0.036

Price($)	Vol.	No.
0.041	977681	6
0.042	2227964	6
0.043	372916	2
0.044	371657	5
0.045	153246	1

Last trade - 10.47am 13/08/2025 (20 minute delay)


Last 4.1¢		Change 0.003 ( 6.49 %)
Open	High	Low	Volume
3.9¢	4.1¢	3.9¢	3325268
Last updated 11.13am 13/08/2025 ?

DVL (ASX) Chart

DORSAVI LTD - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available